267 related articles for article (PubMed ID: 16648551)
1. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
3. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
4. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
5. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
Shmeeda H; Tzemach D; Mak L; Gabizon A
J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
7. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
8. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
9. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
Lee RJ; Low PS
Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
[TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
Pan XQ; Lee RJ
Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.
Kamaly N; Kalber T; Thanou M; Bell JD; Miller AD
Bioconjug Chem; 2009 Apr; 20(4):648-55. PubMed ID: 19368341
[TBL] [Abstract][Full Text] [Related]
14. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
Saul JM; Annapragada A; Natarajan JV; Bellamkonda RV
J Control Release; 2003 Sep; 92(1-2):49-67. PubMed ID: 14499185
[TBL] [Abstract][Full Text] [Related]
15. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes.
Zhao XB; Muthusamy N; Byrd JC; Lee RJ
J Pharm Sci; 2007 Sep; 96(9):2424-35. PubMed ID: 17588260
[TBL] [Abstract][Full Text] [Related]
17. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and properties of folate receptor-targeted cationic liposomes].
Yan Y; Qi XR
Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
[TBL] [Abstract][Full Text] [Related]
20. A folate receptor-targeted liposomal formulation for paclitaxel.
Wu J; Liu Q; Lee RJ
Int J Pharm; 2006 Jun; 316(1-2):148-53. PubMed ID: 16564654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
